Alnylam Pharmaceuticals Inc at Bank of America Merrill Lynch Napa Healthcare Conference (Virtual) Transcript
Good afternoon, everybody. Thanks for joining us. I am Tazeen Ahmad. I'm one of the senior biotech analyst here at Bank of America. Welcome to our virtual Napa conference. As part of this afternoon's session, it's my pleasure to introduce our presenting company, Alnylam. Presenting for Alnylam for the next 50 minutes or so will be CEO, John Maraganore. John, good afternoon. Thank you for joining us.
Thanks, Tazeen. Good afternoon to you and to everybody, and thanks for inviting us.
Questions & Answers
So most people already know the story of Alnylam. And normally, we ask people to give a couple of minute intro. But I think given the audience that we have filed in, I think it makes more sense probably just to dive in to some questions. And so I thought maybe we could talk to you initially about COVID. On your 1Q
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
